Standard BioTools Inc. Common Stock (NASDAQ: LAB) last traded at $0.669, up 3.51% on the session. The quote above updates while this page is open; the figures below are drawn from Standard BioTools Inc. Common Stock’s own filings and are restated only when a new one is published.
Standard BioTools Inc. Common Stock trades on NASDAQ under the ticker LAB. Its market capitalisation is $262.64 million.
Valuation measures for Standard BioTools Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $262.64M |
|---|---|
| Enterprise value | $79.86M |
| P/E ratio | 3.04 |
| Price / sales | 4.10 |
| Price / book | 0.49 |
| Beta | 1.21 |
Trailing-twelve-month figures tagged in Standard BioTools Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $64.02M |
|---|---|
| Net income (TTM) | $84.91M |
| EPS (TTM) | $0.220 |
| Gross margin | 66.71% |
| Operating margin | -149.11% |
| Return on equity | 15.72% |
| Cash | $270.03M |
Range and volume for LAB over the past 52 weeks.
| 52-week high | $1.72 |
|---|---|
| 52-week low | $0.625 |
| Volume | 3.54M |
| Average volume | 3.43M |
| Previous close | $0.646 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.